Literature DB >> 7892432

Platelet serotonin uptake sites increased in drinkers of ayahuasca.

J C Callaway1, M M Airaksinen, D J McKenna, G S Brito, C S Grob.   

Abstract

The binding of [3H]citalopram to the platelet 5-hydroxytryptamine (5-HT) transporter was measured in a group of healthy male drinkers of ayahuasca, a psychoactive sacrament indigenous to Amazonia, and a group healthy male controls. An increased number of binding sites (Bmax) in the platelets of ayahuasca drinkers was found, while the dissociation constant (Kd) remained the same for both groups. If indicative of neuronal 5-HT uptake activity, these results would suggest a decreased concentration of extracellular 5-HT, or a response to increased production and release of 5-HT. Such changes in 5-HT synaptic activity, in this case, should not be misinterpreted as an indication of developing neurological or psychiatric illness.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7892432     DOI: 10.1007/bf02245347

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  12 in total

1.  Mass fragmentographic quantification of urinary N,N-dimethyltryptamine and bufotenine.

Authors:  M Räisänen; J Kärkkäinen
Journal:  J Chromatogr       Date:  1979-04-11

2.  Regulation of high- and low-affinity [3H]imipramine recognition sites in rat brain by chronic treatment with antidepressants.

Authors:  P D Hrdina
Journal:  Eur J Pharmacol       Date:  1987-06-19       Impact factor: 4.432

3.  Age-related differences in human platelet 5-HT uptake.

Authors:  D Marazziti; M F Falcone; A Rotondo; P Castrogiovanni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

Review 4.  Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets.

Authors:  J O Marcusson; S B Ross
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 5.  beta-Carbolines, psychoactive compounds in the mammalian body. Part II: Effects.

Authors:  M M Airaksinen; I Kari
Journal:  Med Biol       Date:  1981-08

6.  Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin and dopamine uptake by human blood platelets.

Authors:  M M Airaksinen; H Svensk; J Tuomisto; H Komulainen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1980-04

7.  Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants.

Authors:  K P Lesch; C S Aulakh; B L Wolozin; T J Tolliver; J L Hill; D L Murphy
Journal:  Brain Res Mol Brain Res       Date:  1993-01

8.  Effect of chronic treatment with selective monoamine oxidase inhibitors and specific 5-hydroxytryptamine uptake inhibitors on [3H]paroxetine binding to cerebral cortical membranes of the rat.

Authors:  D Graham; L Tahraoui; S Z Langer
Journal:  Neuropharmacology       Date:  1987-08       Impact factor: 5.250

9.  [3H]citalopram binding to brain and platelet membranes of human and rat.

Authors:  P Plenge; E T Mellerup
Journal:  J Neurochem       Date:  1991-01       Impact factor: 5.372

10.  Light-dark differences in [3H]-paroxetine binding to rabbit platelet membranes.

Authors:  P Rocca; A M Galzin; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

View more
  8 in total

Review 1.  On the transmethylation hypothesis: stress, N,N-dimethyltryptamine, and positive symptoms of psychosis.

Authors:  Dionysios Grammenos; Steven A Barker
Journal:  J Neural Transm (Vienna)       Date:  2014-11-02       Impact factor: 3.575

2.  Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant.

Authors:  Jordi Riba; Sergio Romero; Eva Grasa; Esther Mena; Ignasi Carrió; Manel J Barbanoj
Journal:  Psychopharmacology (Berl)       Date:  2006-03-31       Impact factor: 4.530

Review 3.  Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.

Authors:  Jerome Sarris; Erica McIntyre; David A Camfield
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

Review 4.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

5.  The Association of Ambient Temperature and Violent Crime.

Authors:  Jari Tiihonen; Pirjo Halonen; Laura Tiihonen; Hannu Kautiainen; Markus Storvik; James Callaway
Journal:  Sci Rep       Date:  2017-07-28       Impact factor: 4.379

6.  Hypothesis: The Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process.

Authors:  Antonio Inserra
Journal:  Front Pharmacol       Date:  2018-04-05       Impact factor: 5.810

Review 7.  Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.

Authors:  Jonathan Hamill; Jaime Hallak; Serdar M Dursun; Glen Baker
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

8.  The pharmacological interaction of compounds in ayahuasca: a systematic review.

Authors:  Simon Ruffell; Nige Netzband; Catherine Bird; Allan H Young; Mario F Juruena
Journal:  Braz J Psychiatry       Date:  2020 Nov-Dec       Impact factor: 2.697

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.